TABLE OF CONTENTS
Volume 25, Issue 34 (7 August 2006)
Guest Editor
Top of pageIntroduction
Mitochondria in cancer
G Kroemer
Oncogene 25: 4630-4632; doi:10.1038/sj.onc.1209589
Reviews
Glycolysis inhibition for anticancer treatment
H Pelicano, D S Martin, R-H Xu and P Huang
Oncogene 25: 4633-4646; doi:10.1038/sj.onc.1209597
Mitochondrial mutations in cancer
M Brandon, P Baldi and D C Wallace
Oncogene 25: 4647-4662; doi:10.1038/sj.onc.1209607
Mitochondrial DNA mutations in human cancer
A Chatterjee, E Mambo and D Sidransky
Oncogene 25: 4663-4674; doi:10.1038/sj.onc.1209604
Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer
A King, M A Selak and E Gottlieb
Oncogene 25: 4675-4682; doi:10.1038/sj.onc.1209594
Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt
R B Robey and N Hay
Oncogene 25: 4683-4696; doi:10.1038/sj.onc.1209595
Mitochondrial factors with dual roles in death and survival
W-C Cheng, S B Berman, I Ivanovska, E A Jonas, S J Lee, Y Chen, L K Kaczmarek, F Pineda and J M Hardwick
Oncogene 25: 4697-4705; doi:10.1038/sj.onc.1209596
Mitochondria and cancer: is there a morphological connection?
E Alirol and J C Martinou
Oncogene 25: 4706-4716; doi:10.1038/sj.onc.1209600
The many shapes of mitochondrial death
G M Cereghetti and L Scorrano
Oncogene 25: 4717-4724; doi:10.1038/sj.onc.1209605
p53 and Nur77/TR3 – transcription factors that directly target mitochondria for cell death induction
U M Moll, N Marchenko and X-k Zhang
Oncogene 25: 4725-4743; doi:10.1038/sj.onc.1209601
The permeability transition pore complex in cancer cell death
C Brenner and S Grimm
Oncogene 25: 4744-4756; doi:10.1038/sj.onc.1209609
Mitochondria in hematopoiesis and hematological diseases
M Fontenay, S Cathelin, M Amiot, E Gyan and E Solary
Oncogene 25: 4757-4767; doi:10.1038/sj.onc.1209606
Contribution of somatic mutations in the mitochondrial genome to the development of cancer and tolerance against anticancer drugs
S Ohta
Oncogene 25: 4768-4776; doi:10.1038/sj.onc.1209602
Hexokinase II: Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria
S P Mathupala, Y H Ko and P L Pedersen
Oncogene 25: 4777-4786; doi:10.1038/sj.onc.1209603
Mitochondriotoxic compounds for cancer therapy
V R Fantin and P Leder
Oncogene 25: 4787-4797; doi:10.1038/sj.onc.1209599
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
S Fulda and K-M Debatin
Oncogene 25: 4798-4811; doi:10.1038/sj.onc.1209608
